Ankasa Regenerative Therapeutics
La Jolla · Founded 2014
About Ankasa Regenerative Therapeutics
Ankasa Regenerative Therapeutics is a biopharmaceutical company developing strategies to improve tissue healing by exploiting the potential of stem cell reactivation. The company is developing proprietary formulations of a potent WNT stem cell activator with the potential to accelerate tissue healing in a broad range of degenerative conditions affecting bone, cartilage, skin, muscle, vasculature, and the central nervous system. Its proprietary approach has demonstrated superiority for bone reformation over existing standards of care in various preclinical models. Ankasa Regenerative Therapeutics was established in 2014 and is headquartered in La Jolla, California.
Company Facts
- Founded: 2014
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $14.5M
- Last round: Series Unknown (Oct 2020)
- Website: https://ankasaregenerativetherapeutics.com/
Industries & Categories
Biopharma, Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ankasa-regenerative-therapeutics-19031 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.